Product NDC: | 0187-2201 |
Proprietary Name: | CeraVe |
Non Proprietary Name: | Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide |
Active Ingredient(s): | 3.5; 3.5; 3.5; 1.75; 16.56 g/70g; g/70g; g/70g; g/70g; g/70g & nbsp; Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LOTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0187-2201 |
Labeler Name: | Valeant Pharmaceuticals North America LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20120827 |
Package NDC: | 0187-2201-01 |
Package Description: | 70 g in 1 TUBE (0187-2201-01) |
NDC Code | 0187-2201-01 |
Proprietary Name | CeraVe |
Package Description | 70 g in 1 TUBE (0187-2201-01) |
Product NDC | 0187-2201 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide |
Dosage Form Name | LOTION |
Route Name | TOPICAL |
Start Marketing Date | 20120827 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Valeant Pharmaceuticals North America LLC |
Substance Name | HOMOSALATE; MERADIMATE; OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE |
Strength Number | 3.5; 3.5; 3.5; 1.75; 16.56 |
Strength Unit | g/70g; g/70g; g/70g; g/70g; g/70g |
Pharmaceutical Classes |